Photo: Milan Markovic/Getty Images
Thesis Care, formerly Trovo Health, has secured $45 million in Series A funding in a round led by Oak HC/FT, bringing its total funding to $60 million.
CRV also participated in the round, alongside Black Opal Ventures and other angel investors.
Thesis offers AI agents within healthcare to assist with clinical operations and care management.
The company will use the funds for commercial expansion, to enhance its technology platform and to expand its care team agents.
"2025 was a defining year for Thesis as we moved from design partnerships into a clear commercial trajectory and growing customer base," Dr. Niren Gandra, CEO and cofounder of Thesis Care, said in a statement.
"We've proven that we can extend clinical capacity and allow our customers to do more for patients at a scale that has historically been impossible. Now, we're ready to bring that to every healthcare organization that needs it."
Adonis, an AI-enabled revenue cycle management platform, has raised $40 million in Series C funding, bringing its total raise to more than $95 million.
Quadrille Capital led the round, with participation from existing investors General Catalyst and Bling Capital.
The New York-based company offers an AI orchestration platform that monitors and detects revenue cycle issues by analyzing claims, denials and payer behavior.
Adonis plans to use the funds to expand its presence with health systems and grow its workforce in New York. It will also accelerate product innovation across its intelligence, AI agents and orchestration platform.
"This funding signals that investors are backing solutions that address the structural problems holding RCM teams back, including RCM workforce shortages, denials, and underpayments," Akash Magoon, cofounder and CEO of Adonis, said in a statement.
"Our mission has always been to restore sanity to RCM, and this investment allows us to accelerate the technology RCM teams need to solve these challenges autonomously and at scale."
Blossom Health, a telehealth platform for psychiatry, announced it raised $20 million in Series A and seed funding.
Headline led the Series A round, with participation from new investors Operator Partners and Correlation Ventures and existing investors Village Global and TA Ventures.
Several angel investors were involved in the round as well, including the founders of General Catalyst, Flatiron Health, Sword Health, Fay, Elemy, Zip, Blank Street, Assured, Bridge, Birches Health and Enzo Health.
Mathias Schilling, cofounder and managing partner of Headline, joined Blossom Health's board of directors.
The company helps individuals seeking mental health support connect with a psychiatrist covered by in-network insurance.
The New York-based company will drive to contract with national and regional health insurance payers, expand its state coverage, invest in research and development to advance its AI and onboard more providers.
